Feature Type | Standardized |
Nominal ANOVA |
||||
---|---|---|---|---|---|---|
mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.31 | 1e-19 |
mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.38 | 8e-17 |
mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.35 | 6e-15 |
mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | 0.27 | 7e-15 |
mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.25 | 2e-14 |
mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.27 | 7e-14 |
mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.24 | 7e-13 |
mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.26 | 1e-12 |
mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.34 | 4e-10 |
mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | 0.32 | 1e-09 |